Dr. Genila Bibat, MD

Claim this profile

Kennedy Krieger Institute

Studies Muscular Dystrophy
Studies Dilated Cardiomyopathy
4 reported clinical trials
5 drugs studied

Area of expertise

1Muscular Dystrophy
Genila Bibat, MD has run 3 trials for Muscular Dystrophy. Some of their research focus areas include:
SMCHD1 mutation positive
D4Z4 repeat contraction positive
2Dilated Cardiomyopathy
Genila Bibat, MD has run 1 trial for Dilated Cardiomyopathy.

Affiliated Hospitals

Image of trial facility.
Kennedy Krieger Institute
Image of trial facility.
Kennedy Krieger Institute Center For Genetic Muscle Disorders

Clinical Trials Genila Bibat, MD is currently running

Image of trial facility.

Oral Ifetroban

for Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a devastating X-linked disease which leads to loss of ambulation between ages 7 and 13, respiratory failure and cardiomyopathy (CM) at any age, and inevitably premature death of affected young men in their late twenties. DMD is the most common fatal genetic disorder diagnosed in childhood. It affects approximately 1 in every 3,500 live male births across all races and cultures, and results in 20,000 new cases each year worldwide.Significant advances in respiratory care have unmasked CM as the leading cause of death. As there are yet no specific cardiac treatments to extend life, the current study aims to address this unmet medical need using a new therapeutic strategy for patients with DMD. Funding Source - FDA OOPD
Recruiting0 awards Phase 23 criteria

More about Genila Bibat, MD

Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Genila Bibat, MD has experience with
  • Ifetroban
  • Placebo
  • Pitolisant Oral Tablet
  • Placebo Oral Tablet
  • Losmapimod
Breakdown of trials Genila Bibat, MD has run
Muscular Dystrophy
Dilated Cardiomyopathy
Cardiomyopathy
Duchenne Muscular Dystrophy
Excessive Sleepiness

Other Doctors you might be interested in

Dejan Budimirovic, MDKennedy Krieger Insitute
Rebecca Landa, PhD, CCC-SLPKennedy Krieger Institute
Jacqueline Harris, MDKennedy Krieger Institute

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Genila Bibat, MD specialize in?
Genila Bibat, MD focuses on Muscular Dystrophy and Dilated Cardiomyopathy. In particular, much of their work with Muscular Dystrophy has involved SMCHD1 mutation positive patients, or patients who are D4Z4 repeat contraction positive.
Is Genila Bibat, MD currently recruiting for clinical trials?
Yes, Genila Bibat, MD is currently recruiting for 1 clinical trial in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Genila Bibat, MD has studied deeply?
Yes, Genila Bibat, MD has studied treatments such as Ifetroban, Placebo, Pitolisant Oral Tablet.
What is the best way to schedule an appointment with Genila Bibat, MD?
Apply for one of the trials that Genila Bibat, MD is conducting.
What is the office address of Genila Bibat, MD?
The office of Genila Bibat, MD is located at: Kennedy Krieger Institute, Baltimore, Maryland 21205 United States. This is the address for their practice at the Kennedy Krieger Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top